Study:
Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
Rationale:
Drugs used in chemotherapy, such as cyclophosphamide and capecitabine, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Giving more than one chemotherapy drug may kill more tumor cells.
Purpose:
This phase II trial is studying how well giving cyclophosphamide together with
capecitabine works in treating women with stage IV breast cancer.
Study Status: Completed
Recruiting:
n/a
| Condition |
Intervention |
Phase |
|
Breast Cancer |
Drug: capecitabine
Drug: cyclophosphamide |
Phase 2 |
Verified by
Southwest Oncology Group
October, 2012
Sponsored by: Southwest Oncology Group
Information provided by: Southwest Oncology Group
ClinicalTrials.gov identifier: NCT00107276
Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States
Community Oncology Group at Cleveland Clinic Cancer Center
Independence, Ohio 44131
United States
Cleveland Clinic - Wooster
Wooster, Ohio 44691
United States
Anne F. Schott, MD., Study Chair
Kathy S. Albain, MD., Study Chair